PeptideDB

Epothilone D (KOS 862) 189453-10-9

Epothilone D (KOS 862) 189453-10-9

CAS No.: 189453-10-9

Epothilone D (formerly known as KOS 862; KOS-862; desoxyepothilone B) is a potent microtubule stabilizing agent that has
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Epothilone D (formerly known as KOS 862; KOS-862; desoxyepothilone B) is a potent microtubule stabilizing agent that has high anticancer activity. It is a naturally occurring polyketide that was separated from Sorangium cellulosum, a myxobacterium. When epothilone D binds to tubulin, it prevents microtubule disintegration, which in turn stops mitosis, cellular growth, and motility.


Physicochemical Properties


Molecular Formula C27H41NO5S
Molecular Weight 491.6831
Exact Mass 491.27
Elemental Analysis C, 65.95; H, 8.40; N, 2.85; O, 16.27; S, 6.52
CAS # 189453-10-9
Related CAS # (16R)-Epothilone D
PubChem CID 447865
Appearance White to light yellow solid powder
Density 1.1±0.1 g/cm3
Boiling Point 657.7±55.0 °C at 760 mmHg
Melting Point 63-66°C
Flash Point 351.6±31.5 °C
Vapour Pressure 0.0±2.1 mmHg at 25°C
Index of Refraction 1.526
LogP 3.69
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 7
Rotatable Bond Count 2
Heavy Atom Count 34
Complexity 777
Defined Atom Stereocenter Count 5
SMILES

S1C(C([H])([H])[H])=NC(=C1[H])/C(/[H])=C(\C([H])([H])[H])/[C@]1([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[H])[C@@]([H])([C@@]([H])(C([H])([H])[H])C(C(C([H])([H])[H])(C([H])([H])[H])[C@]([H])(C([H])([H])C(=O)O1)O[H])=O)O[H] |t:24|

InChi Key XOZIUKBZLSUILX-GIQCAXHBSA-N
InChi Code

InChI=1S/C27H41NO5S/c1-16-9-8-10-17(2)25(31)19(4)26(32)27(6,7)23(29)14-24(30)33-22(12-11-16)18(3)13-21-15-34-20(5)28-21/h11,13,15,17,19,22-23,25,29,31H,8-10,12,14H2,1-7H3/b16-11-,18-13+/t17-,19+,22-,23-,25-/m0/s1
Chemical Name

(4S,7R,8S,9S,13Z,16S)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione
Synonyms

KOS 862; (-)-Desoxyepothilone B; (-)-Epothilone D; KOS-862; 12,13-Deoxyepothilone B; KOS862; 12,13-Desoxyepothilone B; Desoxyepothilone B; Epo D; Epothilone D; NSC 703147.
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets Microtubule/Tubulin
ln Vitro
Epothilone D (KOS-862) exhibits greater potency as a microtubule stabilizer compared to epothilone A or B. In vitro, a panel of human tumor cell lines has demonstrated strong cytotoxicity from epothilone D, which is comparable in potency to paclitaxel. Additionally, epothilone D exhibits a clear benefit over paclitaxel in drug-resistant cell lines and maintained its cytotoxicity in the face of a multidrug-resistant cell line that overexpresses P-glycoprotein[1]. The stabilizing agent for microtubules (MTs) is called epothilone D (EpoD)[2].
ln Vivo
Male PS19 mice that were three months old were divided into groups and given weekly intraperitoneal injections (i.p.) of either vehicle or Epothilone D (EpoD) at doses of either 1 mg/kg or 3 mg/kg for a duration of three months. This was done to assess whether EpoD improves MT and axonal function in PS19 mice. Furthermore, a vehicle or 3 mg/kg of Epothilone D (EpoD) were given to the non-Tg littermates who were 3 months old. Neutropenia, a side effect associated with MT-stabilizing medications, should be minimized in human subjects with the 3 mg/kg Epothilone D (EpoD) dose, which is approximately 10-fold lower than that used in a Phase II clinical study. No evidence of drug intolerance is seen in PS19 or WT mice given epothilone D (EpoD). All mice receiving the drugs did, in fact, show weight gain that was identical to that of animals receiving a vehicle. In mice treated with vehicle and Epothilone D (EpoD), the relative organ weights are also similar. Based on a standard rotarod test, the motor performance of mice treated with Epothilone D (EpoD) does not differ significantly from that of cohorts treated with a vehicle. Furthermore, no treatment cohort's neutrophil content or white blood cell counts differ significantly from one another, despite small group-to-group variability. Epothilone D (EpoD) at low doses used in these investigations therefore seemed to be well tolerated[2].
Animal Protocol Mice: Three groups of mice (n = 3) are given intraperitoneal (i.p.) injections of 3.7 mg/kg of dissolved Epothilone D (epoD) in 100% DMSO. The mice are then put to sleep using approved methods at intervals of 0.25 to 24 hours. In a different study, three groups of mice (n=3) are injected with 3 mg/kg of epoD in 100% DMSO, and four, six, and ten days later, they are put to death. Using LC-MS/MS procedures, the levels of epothilone D (epoD) in brain and blood samples are ascertained. For a duration of three months, groups (n=10–13) of three-month-old PS19 tau Tg mice or their three-month-old non-Tg littermates receive weekly intraperitoneal injections (i.p.) of vehicle (DMSO), 1 mg/kg epoD, or 3 mg/kg epothilone D (ep. Pets are weighed every week and watched for indications of unusual behavior or distress. Testing of the mice's motor and cognitive abilities occurs after the last dosage. Upon euthanasia, the optic nerve (ON) and brain are removed for immunohistochemical examination. An organ weight assessment and necropsy are also performed on a subset of mice from each group.
References

[1]. Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma. Invest New Drugs. 2012 Dec;30(6):2294-302.

[2]. Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. J Neurosci. 2010 Oct 13;30(41):13861-6.

Additional Infomation Epothilone D is an epithilone that is epithilone C in which the hydrogen at position 13 of the oxacyclohexadec-13-ene-2,6-dione macrocycle has been replaced by a methyl group. It has a role as a microtubule-stabilising agent.
Epothilone D has been reported in Myxococcus xanthus, Sorangium cellulosum, and Streptomyces venezuelae with data available.
Epothilone D is a natural polyketide compound isolated from the myxobacterium Sorangium cellulosum. Also known as desoxyepothilone B, epothilone D binds to tubulin and inhibits the disassembly of microtubules, resulting in the inhibition of mitosis, cellular proliferation, and cell motility. (NCI04)
Drug Indication
Investigated for use/treatment in colorectal cancer, lung cancer, breast cancer, solid tumors, and prostate cancer.
Mechanism of Action
The principal mechanism of the epothilone class is inhibition of microtubule function. Microtubules are essential to cell division, and epothilones therefore stop cells from properly dividing.

Solubility Data


Solubility (In Vitro) DMSO: ≥ 100 mg/mL (~203.4 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (5.08 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (5.08 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.0338 mL 10.1692 mL 20.3384 mL
5 mM 0.4068 mL 2.0338 mL 4.0677 mL
10 mM 0.2034 mL 1.0169 mL 2.0338 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.